Staging Procedures to Diagnose Malignant Pleural Mesothelioma

Mayo Clinic33 enrolled

Overview

The purpose of this study is to evaluate the accuracy of participants imaging versus staging procedures. The investigators will consent subjects that are scheduled to undergo staging procedures to diagnose malignant pleural mesothelioma (including pleuroscopy, bronchoscopy, endobronchial ultrasound and laparoscopy) as part of their standard of care.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Mesothelioma Solitary Fibrous Tumor of the Pleura

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Subject provides informed consent * Subject is \>18 years of age * Subject is deemed competent for making medical decisions * Subject is scheduled to undergo a staging pleuroscopy * Subject is a surgical candidate * A negative pregnancy test is required in women of child-bearing potential, as standard of care. Exclusion Criteria: * Subject is \<18 years old.

Locations (1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States

Outcomes

Primary Outcomes

Accuracy of surgical staging versus imaging procedures based on surgical findings.

The staging imaging will be compared with the actual surgical staging procedure to evaluate the accuracy of the imaging.

Time frame: 2 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.